An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study

Pancreatic safety of sodium‐glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

(2020) Huilin Tang et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems

(2020) Louis Dijkstra et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study

(2020) Zhong Yuan et al.   CURRENT MEDICAL RESEARCH AND OPINION

Is aggressive intravenous fluid resuscitation beneficial in acute pancreatitis? A meta-analysis of randomized control trials and cohort studies

(2020) Mohamed M Gad et al.   WORLD JOURNAL OF GASTROENTEROLOGY

AKI Associated with Acute Pancreatitis

(2019) Tareq I. Nassar et al.   Clinical Journal of the American Society of Nephrology

Evaluation and management of acute pancreatitis

(2019) Ahmed T Chatila et al.   World Journal of Clinical Cases

PDB111 EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE

(2019) V. Sharma et al.   VALUE IN HEALTH

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

(2019) Elad Shemesh et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis

(2018) Seth D. Crockett et al.   GASTROENTEROLOGY

Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials

(2018) Daisuke Yabe et al.   Journal of Diabetes Investigation

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETOLOGIA

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

(2018) Joe-Elie Salem et al.   LANCET ONCOLOGY

Acute pancreatitis: Trends in outcomes and the role of acute kidney injury in mortality- A propensity-matched analysis

(2018) Kalpit Devani et al.   PANCREATOLOGY

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

(2018) Peter Ueda et al.   BMJ-British Medical Journal

Concurrent Diabetic Ketoacidosis in Hypertriglyceridemia-Induced Pancreatitis

(2017) Yuchen Wang et al.   PANCREAS

VigiBase, the WHO Global ICSR Database System: Basic Facts

(2017) Marie Lindquist   DRUG INFORMATION JOURNAL

Canagliflozin-Associated Acute Pancreatitis

(2016) Rajanshu Verma   AMERICAN JOURNAL OF THERAPEUTICS

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis

(2016) F. Zaccardi et al.   DIABETES OBESITY & METABOLISM

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2015) Silvio E. Inzucchi et al.   DIABETOLOGIA

PANCREATIC KETOACIDOSIS (KABADI SYNDROME) MIMICKING DIABETIC KETOACIDOSIS

(2015) Udaya M. Kabadi   Endocrine Practice

Canagliflozin-induced pancreatitis: a rare side effect of a new drug

(2015) Mudit Chowdhary et al.   Therapeutics and Clinical Risk Management

Choosing Thresholds for Statistical Signal Detection with the Proportional Reporting Ratio

(2013) Jim Slattery et al.   DRUG SAFETY

Increased Risk of Acute Pancreatitis in Patients with Type 2 Diabetes: An Observational Study Using a Japanese Hospital Database

(2012) Hisashi Urushihara et al.   PLoS One